Gateway Analytical: Setting New Standards in Early-Phase Analytical Testing
When it comes to healthcare, ensuring...
Gateway Analytical to Attend The Alliance for Regenerative Medicine’s Cell & Gene ‘Meeting on the Mesa’ 2023
Gateway Analytical is excited to attend...
Gateway Analytical at CPHI Barcelona 2023: Where Science Meets Innovation
Gateway Analytical at CPHI Barcelona 2023:...
Gateway Analytical to Promote Medical Device Testing Services at the 7th Annual Pharmaceutical and Medical Device Manufacturing and Quality Operations Forum
Gateway Analytical announced today that they...
DDL 2012: Assessment of Drugs and Carrier PSD in a Commercial Combinational Dry Powder Inhaler Post Multistage Cascade Impaction Analysis by Raman Imaging
December 07, 2012
Gateway Analytical Acquires RapID System to Meet Growing Market Demand
PITTSBURGH, January, 21 2014 — Gateway...
RDD 2012: Investigation of the Microstructure of Combination Dry Powder Inhaler Formulations by Atomic Force Microscopy and Raman Chemical Imaging
May 20, 2012 The microstructure of combination DPI formulations is complex and is related to the surface interfacial interactions between components of the formulation, which define the structure and thereby performance of the formulation (1, 2, 3). Previous studies have attempted to investigate the microstructure of combination DPI formulations using…
Gateway Analytical Receives Controlled Substance Registration Certificate from the Drug Enforcement Administration
Gateway Analytical is proud to announce...